Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
2.

Cost-effectiveness of varicella vaccination programs: an update of the literature.

Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ.

Expert Rev Vaccines. 2008 Aug;7(6):753-82. doi: 10.1586/14760584.7.6.753. Review.

PMID:
18665775
3.
4.

Varicella vaccination in Australia.

Macartney KK, Beutels P, McIntyre P, Burgess MA.

J Paediatr Child Health. 2005 Nov;41(11):544-52. Review.

PMID:
16398834
5.

Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.

Valentim J, Sartori AM, de Soárez PC, Amaku M, Azevedo RS, Novaes HM.

Vaccine. 2008 Nov 18;26(49):6281-91. doi: 10.1016/j.vaccine.2008.07.021. Epub 2008 Jul 30.

PMID:
18674582
6.

The economic value of childhood varicella vaccination in France and Germany.

Coudeville L, Brunot A, Szucs TD, Dervaux B.

Value Health. 2005 May-Jun;8(3):209-22.

7.

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O.

BMC Public Health. 2015 Jun 5;15:533. doi: 10.1186/s12889-015-1861-8. Review.

8.

Economic evaluations of varicella vaccination programmes: a review of the literature.

Thiry N, Beutels P, Van Damme P, Van Doorslaer E.

Pharmacoeconomics. 2003;21(1):13-38. Review.

PMID:
12484801
9.
10.

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.

Scuffham P, Devlin N, Eberhart-Phillips J, Wilson-Salt R.

Soc Sci Med. 1999 Sep;49(6):763-79.

PMID:
10459888
11.

The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.

Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D.

Can Commun Dis Rep. 2007 Nov 1;33(11):1-15. English, French. No abstract available.

12.

An outbreak of varicella despite vaccination.

Wack RP.

N Engl J Med. 2003 Apr 3;348(14):1405-7; author reply 1405-7. No abstract available.

PMID:
12678025
13.

Varicella-zoster virus vaccine.

White CJ.

Clin Infect Dis. 1997 May;24(5):753-61; quiz 762-3. Review. No abstract available.

PMID:
9142766
14.

The case against universal varicella vaccination.

Goldman GS.

Int J Toxicol. 2006 Sep-Oct;25(5):313-7.

PMID:
16940003
15.

Instituting a routine varicella vaccination program in Canada: an economic evaluation.

Getsios D, Caro JJ, Caro G, De Wals P, Law BJ, Robert Y, Lance JM.

Pediatr Infect Dis J. 2002 Jun;21(6):542-7.

PMID:
12182379
16.

The cost-effectiveness of varicella vaccination in Canada.

Brisson M, Edmunds WJ.

Vaccine. 2002 Jan 15;20(7-8):1113-25.

PMID:
11803072
17.

The cost-effectiveness of routine childhood varicella vaccination in Germany.

Banz K, Wagenpfeil S, Neiss A, Goertz A, Staginnus U, Vollmar J, Wutzler P.

Vaccine. 2003 Mar 7;21(11-12):1256-67.

PMID:
12559807
18.

Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.

Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB.

Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):693-6.

PMID:
15689089
19.

Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.

Hoshi SL, Kondo M, Okubo I.

Vaccine. 2017 May 31;35(24):3264-3271. doi: 10.1016/j.vaccine.2017.04.046. Epub 2017 May 4.

PMID:
28479176
20.

Routine vaccination against chickenpox?

[No authors listed]

Drug Ther Bull. 2012 Apr;50(4):42-5. doi: 10.1136/dtb.2012.04.0098. Review.

PMID:
22495050

Supplemental Content

Support Center